Your browser doesn't support javascript.
loading
Upper Respiratory Tract Co-detection of Human Endemic Coronaviruses and High-density Pneumococcus Associated With Increased Severity Among HIV-Uninfected Children Under 5 Years Old in the PERCH Study.
Park, Daniel E; Higdon, Melissa M; Prosperi, Christine; Baggett, Henry C; Brooks, W Abdullah; Feikin, Daniel R; Hammitt, Laura L; Howie, Steve R C; Kotloff, Karen L; Levine, Orin S; Madhi, Shabir A; Murdoch, David R; O'Brien, Katherine L; Scott, J Anthony G; Thea, Donald M; Antonio, Martin; Awori, Juliet O; Baillie, Vicky L; Bunthi, Charatdao; Kwenda, Geoffrey; Mackenzie, Grant A; Moore, David P; Morpeth, Susan C; Mwananyanda, Lawrence; Paveenkittiporn, Wantana; Ziaur Rahman, Mohammed; Rahman, Mustafizur; Rhodes, Julia; Sow, Samba O; Tapia, Milagritos D; Deloria Knoll, Maria.
Afiliación
  • Park DE; From the Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Higdon MM; Department of Environmental and Occupational Health, Milken Institute School of Public Health, George Washington University, Washington, District of Columbia.
  • Prosperi C; From the Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Baggett HC; From the Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Brooks WA; Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Feikin DR; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Hammitt LL; International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Bangladesh.
  • Howie SRC; From the Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Kotloff KL; From the Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Levine OS; Medical Research Council Unit, Basse, The Gambia.
  • Madhi SA; Department of Paediatrics, University of Auckland, New Zealand.
  • Murdoch DR; Department of Pediatrics and Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland.
  • O'Brien KL; From the Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Scott JAG; Bill & Melinda Gates Foundation, Seattle, Washington.
  • Thea DM; Medical Research Council: Respiratory and Meningeal Pathogens Research Unit.
  • Antonio M; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Awori JO; Department of Pathology and Biomedical Sciences, University of Otago.
  • Baillie VL; Microbiology Unit, Canterbury Health Laboratories, Christchurch, New Zealand.
  • Bunthi C; From the Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Kwenda G; KEMRI Wellcome Trust Research Programme, Centre for Geographic Medicine Research, Coast, Kilifi, Kenya.
  • Mackenzie GA; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Moore DP; Department of Global Health and Development, Boston University School of Public Health, Boston, Massachusetts.
  • Morpeth SC; Medical Research Council Unit, Basse, The Gambia.
  • Mwananyanda L; Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine.
  • Paveenkittiporn W; Microbiology and Infection Unit, Warwick Medical School, University of Warwick, Coventry, United Kingdom.
  • Ziaur Rahman M; KEMRI Wellcome Trust Research Programme, Centre for Geographic Medicine Research, Coast, Kilifi, Kenya.
  • Rahman M; Medical Research Council: Respiratory and Meningeal Pathogens Research Unit.
  • Rhodes J; Division of Global Health Protection, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
  • Sow SO; Right to Care-Zambia.
  • Tapia MD; Department of Biomedical Sciences, School of Health Sciences, University of Zambia, Lusaka, Zambia.
  • Deloria Knoll M; Medical Research Council Unit, Basse, The Gambia.
Pediatr Infect Dis J ; 40(6): 503-512, 2021 06 01.
Article en En | MEDLINE | ID: mdl-33883479
BACKGROUND: Severity of viral respiratory illnesses can be increased with bacterial coinfection and can vary by sex, but influence of coinfection and sex on human endemic coronavirus (CoV) species, which generally cause mild to moderate respiratory illness, is unknown. We evaluated CoV and pneumococcal co-detection by sex in childhood pneumonia. METHODS: In the 2011-2014 Pneumonia Etiology Research for Child Health study, nasopharyngeal and oropharyngeal (NP/OP) swabs and other samples were collected from 3981 children <5 years hospitalized with severe or very severe pneumonia in 7 countries. Severity by NP/OP detection status of CoV (NL63, 229E, OC43 or HKU1) and high-density (≥6.9 log10 copies/mL) pneumococcus (HDSpn) by real-time polymerase chain reaction was assessed by sex using logistic regression adjusted for age and site. RESULTS: There were 43 (1.1%) CoV+/HDSpn+, 247 CoV+/HDSpn-, 449 CoV-/HDSpn+ and 3149 CoV-/HDSpn- cases with no significant difference in co-detection frequency by sex (range 51.2%-64.0% male, P = 0.06). More CoV+/HDSpn+ pneumonia was very severe compared with other groups for both males (13/22, 59.1% versus range 29.1%-34.7%, P = 0.04) and females (10/21, 47.6% versus 32.5%-43.5%, P = 0.009), but only male CoV+/HDSpn+ required supplemental oxygen more frequently (45.0% versus 20.6%-28.6%, P < 0.001) and had higher mortality (35.0% versus 5.3%-7.1%, P = 0.004) than other groups. For females with CoV+/HDSpn+, supplemental oxygen was 25.0% versus 24.8%-33.3% (P = 0.58) and mortality was 10.0% versus 9.2%-12.9% (P = 0.69). CONCLUSIONS: Co-detection of endemic CoV and HDSpn was rare in children hospitalized with pneumonia, but associated with higher severity and mortality in males. Findings may warrant investigation of differences in severity by sex with co-detection of HDSpn and SARS-CoV-2.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Infecciones del Sistema Respiratorio / Infecciones por Coronavirus / Coinfección Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Pediatr Infect Dis J Asunto de la revista: DOENCAS TRANSMISSIVEIS / PEDIATRIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Infecciones del Sistema Respiratorio / Infecciones por Coronavirus / Coinfección Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Pediatr Infect Dis J Asunto de la revista: DOENCAS TRANSMISSIVEIS / PEDIATRIA Año: 2021 Tipo del documento: Article